|
MKI67IP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.44169137633799E-15 |
| Normal-vs-Stage2 |
1.6184299999944E-05 |
| Normal-vs-Stage3 |
1.86883841735153E-12 |
| Normal-vs-Stage4 |
3.71820019218205E-10 |
| Stage1-vs-Stage2 |
9.979800E-01 |
| Stage1-vs-Stage3 |
6.901500E-02 |
| Stage1-vs-Stage4 |
1.001760E-01 |
| Stage2-vs-Stage3 |
2.426200E-01 |
| Stage2-vs-Stage4 |
2.415000E-01 |
| Stage3-vs-Stage4 |
8.935200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
2.12129999999089E-06 |
| Normal-vs-Asian |
1.139650E-02 |
| Caucasian-vs-AfricanAmerican |
2.072600E-01 |
| Caucasian-vs-Asian |
9.257800E-02 |
| AfricanAmerican-vs-Asian |
5.551400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33066907387547E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.565800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.763540E-04 |
| Normal-vs-Age(41-60Yrs) |
1.67477143264705E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.898200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.923800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.611600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.096200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.117400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.379800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.526600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.501950E-02 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
1.66155977865401E-12 |
| Normal-vs-Grade 4 |
2.21350000551013E-08 |
| Grade 1-vs-Grade 2 |
4.408400E-01 |
| Grade 1-vs-Grade 3 |
7.576400E-01 |
| Grade 1-vs-Grade 4 |
5.457800E-01 |
| Grade 2-vs-Grade 3 |
1.625420E-01 |
| Grade 2-vs-Grade 4 |
9.339200E-01 |
| Grade 3-vs-Grade 4 |
4.258200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
5.71809266602941E-12 |
| ccA subtype-vs-ccB subtype |
4.278600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.66133814775094E-16 |
| Normal-vs-N1 |
5.120000E-03 |
| N0-vs-N1 |
2.371800E-01 |
|
|
